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Abstract 
To date, brain imaging has largely relied on X-ray computed tomography and magnetic 
resonance angiography with limited spatial resolution and long scanning times. Fluorescence-
based brain imaging in the visible and traditional near-infrared regions (400-900 nm) is an 
alternative but currently requires craniotomy, cranial windows and skull thinning techniques, and 
the penetration depth is limited to 1-2 mm due to light scattering. Here, we report through-scalp 
and through-skull fluorescence imaging of mouse cerebral vasculature without craniotomy 
utilizing the intrinsic photoluminescence of single-walled carbon nanotubes in the 1.3-1.4 
micrometre near-infrared window (NIR-IIa window). Reduced photon scattering in this spectral 
region allows fluorescence imaging reaching a depth of >2 mm in mouse brain with sub-10 
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micrometre resolution. An imaging rate of ~5.3 frames/s allows for dynamic recording of blood 
perfusion in the cerebral vessels with sufficient temporal resolution, providing real-time 
assessment of blood flow anomaly in a mouse middle cerebral artery occlusion stroke model.  
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Introduction 
The essential functions of the brain dictate that any significant cerebral dysfunction or disease, 
such as the cerebrovascular disease, could lead to severe morbidity or mortality.
1
 Brain imaging 
has relied on X-ray computed tomography (CT) and magnetic resonance angiography (MRA) to 
reach sufficient penetration depth,
2-4
 but these modalities are limited in spatial resolution (~ sub-
millimeter) and long scanning times (~ minutes),
5-7
 impairing the resolution of small vessels and 
dynamic blood flow in the brain. On the other hand, fluorescence-based optical imaging of the 
brain in the visible and traditional near-infrared regions (400-900 nm) has relied on craniotomy, 
cranial windows and skull thinning techniques
8-11
 and the penetration depth for in vivo brain 
imaging has been limited to a depth of 1-2 mm
8,12-14
 by light scattering.
15,16
  
Recently, we and others have shown that biological imaging with carbon nanotube and 
quantum dot fluorescent agents in the long near-infrared region (1.0-1.7 m, named NIR-II 
region) can benefit from reduced tissue scattering and autofluorescence, reaching deeper 
penetration depths in vivo than traditional NIR (NIR-I, 750-900 nm) imaging techniques.
17-29
 
Photon scattering scales as    , where             for biological tissues. The reduced 
scattering in the NIR-II region has allowed in vivo fluorescence imaging of blood vessels in the 
hindlimb of mice with ~30 m lateral resolution at > 1 mm depth.22 Here, we report the first non-
invasive brain imaging in a narrow 1.3-1.4 m region (named as the NIR-IIa region), allowing 
penetration through intact scalp and skull and resolving cerebral vasculatures with a previously 
unattainable spatial resolution of sub-10 m at a depth of >2 mm underneath the surface of the 
scalp skin in an epifluorescence imaging mode. The 1.3-1.4 m NIR-IIa window is rationally 
chosen for in vivo imaging so as to minimize scattering by rejecting shorter wavelength photons 
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than 1.3 m while avoiding increase light absorption by water vibrational overtone modes above 
~1.4 m. Further, dynamic NIR-IIa cerebrovascular imaging with high temporal resolution (< 
200 ms/frame) was used to reveal drastically reduced blood flow due to arterial occlusion in an 
acute stroke model on mice. 
 
Results 
Phantom Imaging in NIR-I, NIR-II and NIR-IIa Regions. We first used a highly scattering 
medium (Intralipid ®, 1 wt% aqueous solution) as a mimic to biological tissue
20
 and studied the 
penetration depths of fluorescence imaging in the NIR-I (<900 nm), NIR-II (1.0-1.7 m) and 
NIR-IIa (1.3-1.4 m) regions. High pressure CO conversion (HiPCO) single-walled carbon 
nanotube
30
 (SWNT)-IRDye800 conjugates excited by an 808-nm laser were used as emitters 
fluorescing in a wide 800 – 1700 nm span (for side-by-side comparing imaging with IRDye800 
that emits in the 800-900 nm NIR-I window, and with SWNT that emits in the 1000-1700 nm 
NIR-II window),
31,32
 using optical filters to select detection and imaging wavelength ranges (Fig. 
1a). When a capillary tube filled with the SWNT-IRDye800 solution was immersed in an 
Intralipid solution at 1 mm depth, sharp images were obtained in all three spectral windows (Fig. 
1b, top). However, when the sample immersion depth increased to 1 cm in Intralipid, scattering 
of photons became obvious in the entire NIR-II (1.0-1.7 m) region and was more severe in the 
NIR-I (< 900 nm) region, causing the image of the capillary tube to be smeared and invisible 
(Fig. 1b, bottom). In contrast, an image taken in the 1.3-1.4 m NIR-IIa region resolved sharp 
edges of the capillary tube even at 1 cm immersion depth in Intralipid (Fig. 1b bottom right 
image), suggesting reduced scattering. The observed wavelength dependence of phantom 
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imaging (Fig. 1b & S1) could be rationalized by considering the measured scattering coefficient 
vs. wavelength for 1% Intralipid (red curve, Fig. 1c, in agreement with previously reported 
reduced scattering coefficient of   
           , blue curve. In this case, and those to follow,   
  
is the scattering coefficient in      and   is the wavelength in   , with the prefactor in 
appropriate unit to make units consistent on both sides of the equation).
33
 The curves exhibited 
photon scattering scaling inversely proportional with wavelength. Rejecting shorter wavelength 
photons below 1.3 m led to drastically improved imaging by avoiding feature smearing and 
background signals caused by scattering of short-wavelength photons. The increased absorption 
in the >1.4-m region (peak shown in Fig. 1c) was due to light excitation of the first overtone 
vibration of water molecules in the Intralipid solution (Fig. 1c and S2)
34
 and was also excluded 
from the NIR-IIa imaging window. 
 
Live Mouse Brain Imaging in NIR-I, NIR-II and NIR-IIa Regions. We performed non-invasive 
in vivo cerebrovascular fluorescence imaging of healthy C57Bl/6 mice with the same SWNT-
IRDye800 conjugates in several spectral windows. A solution of SWNT-IRDye800 was injected 
intravenously through the tail (see Methods) of a mouse. The head of the mouse with hair shaved 
off (Fig. 2a) was imaged without craniotomy in the NIR-I (< 900 nm), NIR-II (1.0-1.7 m) and 
NIR-IIa (1.3-1.4 m) regions respectively (pixel size = 78 m) under an 808-nm laser 
illumination (Fig. S3). In contrast to the blurry vasculatures imaged in the < 900 nm NIR-I 
region (Fig. 2b), much sharper images were obtained by detecting longer wavelength photons 
(Fig. 2c), and the sharpest and highest resolution images of brain vessels were seen in the 1.3-1.4 
m NIR-IIa region (Fig. 2d). Similar to the Intralipid phantom imaging case, rejecting the 
shorter wavelength < 1.3 m photons significantly reduced background signals and vessel 
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blurriness caused by scattering, and improved signal/background ratio and imaging quality. The 
cerebral angiogram taken in the 1.3-1.4 m NIR-IIa region clearly showed the inferior cerebral 
vein (labeled as 1), the superior sagittal sinus (labeled as 2) and transverse sinus (labeled as 3) at 
~1-2 mm depths under the scalp skin (Fig. S4), along with other cortical vessels in both cerebral 
hemispheres (Fig. 2d). A 360-degree rotational view of the mouse head was also recorded in the 
1.3-1.4 m NIR-IIa region to show a 3D perspective of the mouse head (Movie S1).  
The wavelength dependence of fluorescence imaging of mouse brain can be gleaned by 
inspecting the extinction spectra of the scalp skin and the cranial bone (i.e., the skull), both of 
which feature a water overtone vibration absorption peak above ~ 1.4 m and a declining photon 
scattering profile (Fig. 2e). To examine the effect of scattering, we plotted reduced scattering 
coefficients   
  of these tissues versus wavelength   (Fig. 2f), based on the empirical formulas 
given in previous literature (  
  (     )                      , where the two terms are 
attributed to Rayleigh and Mie scattering respectively;   
  (     )             ; and 
  
  (            )             ) 8,35,36. It can be seen from the plotted scattering profiles that the 
reduced photon scattering coefficients in the NIR-IIa range (1.54 mm
-1
 for scalp and 1.42 mm
-1
 
for skull at 1350 nm) were lower than in the traditional NIR-I window (1.96 mm
-1
 for scalp and 
1.99 mm
-1
 for skull at 800 nm). A simple estimate suggested that the lower scattering 
coefficients in NIR-IIa corresponded to ~47% fewer scattered photons through the scalp and 
skull than in the NIR-I region based on the measured scalp thickness of 0.7 mm and the 
measured skull thickness of 0.6 mm. These factors led to drastically improved imaging of mouse 
cortical vessels underneath the cranial bone in the NIR-IIa region (Fig. 2d vs. 2b). 
 
7 
 
High Resolution Cerebral Imaging in the NIR-IIa Window. We then used microscopic 
objectives to image cerebral vessels with high resolution at 15-fold (pixel size ~ 5 m) and 30-
fold (pixel size ~ 2.5 m) higher magnification than used for Fig. 2. A home-made stereotactic 
platform was used to eliminate motion of the mouse head and a 3D translational stage with 
digital readout allowed us to measure the imaging focal depth inside the brain (Fig. 3a&b). 
Further, chemical separation of large-diameter semiconducting (LS) nanotubes in the HiPCO 
material (see Methods for separation details) was performed and the LS tubes with fluorescence 
emission biased towards the favorable 1.3-1.4 m region were used for brain imaging to 
optimize signal on the per unit mass basis of the injected nanotube dose (Fig. 3c and S5). We 
imaged the entire mouse head (Fig. 3d), zoomed into its left hemisphere (Fig. 3e) and then 
performed microscopic imaging near the location of a cortical vessel branching from the superior 
sagittal sinus. A typical microscopic image of the brain vessels taken in the 1.3-1.4 m NIR-IIa 
region focused at a depth of 2.6 mm below the surface of the scalp (Fig. 3f; depth of focal plane 
was determined by the axial travel distance of the digitally controlled stage relative to the 
objective, as described in Methods) revealed many tiny capillary vessels branching from the 
larger vessels.  Cross-sectional intensity profile of one of the capillary vessels in Fig. 3g showed 
a Gaussian-fitted full width at half maximum (FWHM) of 6.6 m (Fig. 3g inset). Based on our 
ex vivo measurement of the total thickness of scalp skin, skull and the meninges as ~1.3 mm 
(Fig. S4), this capillary vessel located at a depth of 2.6 mm was ~ 1.3 mm deep (2.6 mm˗1.3 mm) 
within the brain tissue.  This represented the highest resolution non-invasive fluorescence 
imaging of brain capillary vessels reported to date (see Fig. 3h-k and Fig. S6 for more brain 
capillaries imaged with 3 different mice at 1-3 mm depths).  
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Statistical analysis of measured capillary vessel widths revealed an average vessel width 
of 9.4 ± 2.5 m, based on 63 different capillary vessels with widths ranging from 5 m to 15 m 
taken from a series of microscopic cerebral vascular images (Fig. S7). The brain imaging depth 
was limited to < 3 mm for our wide-field epifluorescence microscopic imaging setup. This limit 
was likely set by the interference from out-of-focus signals, most notably fluorescence from 
foreground vessels on the path of the laser beam prior to the focal plane.
37
 We envisage a two-
photon fluorescence microscope with NIR-IIa excitation should solve this problem and generate 
optically sectioned images with three-dimensional reconstruction of capillary networks to even 
deeper penetration depths in the brain, using traditional fluorescent dyes excitable around 600-
700 nm in the one-photon absorption process. 
 
Dynamic NIR-IIa Fluorescence Imaging of Cerebral Blood Perfusion. Immediately after tail-
vein injection of SWNTs into a healthy control mouse (Mouse C1), we performed dynamic brain 
imaging (frame rate = 5.3 frame per second) and observed the NIR-IIa signal arising from the 
lateral sulcus on both sides of the cerebrum within 3 s (Fig. 4a & Movie S2), before the interior 
cerebral vein, the superior sagittal sinus and the transverse sinus started showing up after 4 s 
owing to the outflow of SWNTs into the venous vessels (Fig. 4b&c). Principal component 
analysis (PCA) was applied to the time-course images over a time course of ~20 s and 
discriminated the arterial vessels (red, Fig. 4d) from the venous vessels (blue, Fig. 4e) based on 
their haemodynamic difference (Fig. 4f).
20,22
 The injected SWNTs kept circulating in the blood 
for at least 3 h post injection, allowing for static imaging in this time window (Fig. S8). We then 
repeated the study in mice with surgically induced middle cerebral artery occlusion (MCAO) as a 
model for stroke to the left cerebral hemisphere. After injection of an SWNT solution into a 
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mouse with MCAO (Mouse M1), the right hemisphere exhibited very similar blood flow to the 
healthy Mouse C1, while the left hemisphere with MCAO showed a marked delay of blood flow 
revealed by NIR-IIa fluorescence (Fig. 4g-i, Movie S3). PCA analysis of Mouse M1 revealed a 
more extended venous vessel network (blue) in the right cerebral hemisphere than in the left, and 
the arterial vessels (red) only showed up in the intact right hemisphere (Fig. 4j-l).  Similar results 
were reproduced with several healthy mice (Fig. S9a-h) and MCAO diseased mice (Fig. S10a-l).  
The dynamic NIR-IIa fluorescence imaging allowed us to quantify cerebral blood 
perfusion by measuring average NIR-IIa intensity in the region of MCAs.
22
 In the healthy Mouse 
C1, the linearly rising fluorescence signals in both cerebral hemispheres had almost identical 
slopes, suggesting a relative perfusion of ~1 (see SI for perfusion analysis) (Fig. 4m; Fig. S9i&j 
for repeat). However, in Mouse M1 with MCAO, the relative perfusion in the occluded left 
hemisphere was only 0.159 (Fig. 4n; Fig. S10m-o for repeat). Another group of mice (n=4) with 
cerebral hypoperfusion as a model of circulatory shock was imaged (Fig. S11) to reveal a 
decrease of blood perfusion of ~20% compared to a dramatic decrease of blood perfusion of 
~85% in the MCAO group (red bars, Fig. 4o). The data agreed with laser Doppler measurements 
(blue bars, Fig. 4o). One advantage of NIR-IIa dynamic fluorescence imaging is that it tracks 
blood flow in a wide-field imaging setup, which allows for simultaneous tracking of blood flow 
in multiple vessels and could potentially provide a complementary method to two-photon 
microscopy based blood flow measurement, which performs line scan along the direction of one 
single vessel at a time with kHz temporal resolution.
38-40
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Discussion 
The NIR-IIa fluorescence imaging method is advantageous for brain imaging in terms of high 
resolution, deep penetration depth and non-invasive nature without the need for craniotomy. 
Previously, imaging in the traditional NIR-I region (750-900 nm) has observed sub-10 m 
capillary vessels at ~350 m depth with craniotomy to remove scattering extracerebral tissues,12 
much shallower than the imaging depth of >2 mm below the scalp in the NIR-IIa region without 
craniotomy. This striking difference can be rationalized by considering the highly scattering 
nature of the brain tissue, with a large scattering coefficient of ~ 7.49 mm
-1
 at 800 nm versus ~ 
2.54 mm
-1
 at 1350 nm (Fig. 2f), suggesting ~10
4
 times greater scattered photons in NIR-I than in 
NIR-IIa through a ~ 2 mm thick brain tissue. Two- and multi-photon microscopy techniques 
have reported a typical penetration depth of 1-2 mm in the brain tissue, facilitated by highly 
localized non-linear excitation and detection;
8,13,14,41
 but scalp and skull usually need to be 
removed and replaced with a cranial window,
8,9
 or polished and thinned
10,11
 to allow for deeper 
penetration depth. Similarly, the invasive removal of the overlying tissues such as the scalp and 
the skull is involved for brain angiography with laser speckle contrast imaging (LSCI)
42,43
 and 
optical frequency domain imaging (OFDI),
44
 which have been reported to reach a high spatial 
resolution of ~10 m in vivo.44,45 To avoid the invasive treatment of the extracerebral tissue, 
optical coherence tomography (OCT) and photoacoustic microscopy have both shown the 
capability of visualizing cortical vasculature at the cost of spatial resolution (10-100 m), unable 
to resolve sub-10 m capillary vessels in vivo. In light of the possible inflammatory responses 
such as altered pial blood vessels induced by invasive extracerebral treatment,
10
 the NIR-IIa 
fluorescence based brain angiography provides a completely non-invasive method to visualize 
the brain vasculature in live mouse with unprecedented resolution and penetration depth. 
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Although the maximum penetration depth of < 3 mm in this work prevents it from 
clinical imaging of much deeper vasculature inside the human brain, our new brain imaging 
method based on the long-wavelength NIR-IIa fluorescence can serve as a non-invasive 
biomedical imaging tool of understanding the mechanisms of the impaired neurovascular and 
neurometabolic regulation on both cortical and sub-cortical levels in animal model studies. 
Besides the cerebrovascular dynamics probed with NIR-IIa fluorescence in this work, we also 
envisage non-invasive brain imaging of neuronal and/or glial network activity with cellular 
resolution in live mice using neuronal activity indicators labeled with NIR-IIa fluorophores. In 
the long term, we anticipate fluorescence imaging using novel, metabolizable fluorophores with 
even longer emission wavelengths and less scattering to be eventually applied to diagnosis and 
monitor of cerebral vascular anomaly such as arteriovenous malformation and brain tumor, and 
other neurovascular disregulations involving rapid modification of cerebral blood flow, such as 
migraine.  
 
Conclusions 
In this work, we explored a new biological transparent sub-window in the 1.3-1.4m, i.e., NIR-
IIa region and performed non-invasive brain imaging in this window by penetrating through the 
intact skin and skull. We resolved cerebral vasculatures with a high spatial resolution of sub-10 
m at a depth of >2 mm in an epifluorescence imaging mode. Compare to previous NIR-II work, 
we found that the 1.3-1.4 m NIR-IIa window for in vivo imaging can further reduce tissue 
scattering by rejecting shorter wavelength photons than 1.3 m. The truly non-invasive nature 
and dynamic imaging capability of NIR-IIa cerebrovascular imaging could allow for high spatial 
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and temporal resolution imaging to follow biological processes in the brain at the molecular 
scale. Future work will develop novel high quantum yield NIR-IIa fluorophores, 3D in vivo 
imaging through confocal or two photon techniques, all of which could lead to further advances 
of in vivo optical imaging.    
 
Methods 
Preparation of water-soluble and biocompatible SWNT-IRDye800 multicolor emitter. The 
preparation of water soluble and biocompatible SWNTs is based upon the detailed procedure 
described in another publication of our group with some modifications.
46
 In brief, raw HiPCO 
SWNTs (Unidym) were suspended in an aqueous solution containing 1 wt% sodium 
deoxycholate by 1 hour of bath sonication. This suspension was then ultracentrifuged at 300,000 
g to remove the nanotube bundles and other large aggregates. The supernatant was retained after 
ultracentrifugation and 0.75 mg·ml
-1
 of DSPE-mPEG(5 kDa) (1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy(polyethyleneglycol, 5000)], Laysan Bio) along with 0.25 
mg·ml
-1
 of DSPE-PEG(5 kDa)-NH2 (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[amino(polyethyleneglycol, 5000)], Laysan Bio) was added to the supernatant. The resulting 
suspension was sonicated in a bath sonicator briefly for 5 min and then dialyzed in a 3500 Da 
membrane (Fisher) against 1x phosphate buffer saline (PBS) solution at pH 7.4 with a minimum 
of six bath changes and a minimum of two hours between changes of water bath. To remove 
aggregates formed during dialysis, the suspension was ultracentrifuged again for 30 min at 
300,000 g. This surfactant-exchanged SWNT sample has lengths ranging between 100 nm and 
2.0 μm with the average length of ~500 nm. These amine-functionalized SWNTs were further 
conjugated with IRDye800 dye molecules according to the protocol developed in our group.
47
 
Briefly, the as-made SWNT solution was concentrated down to ~2 M after removal of excess 
surfactant through 30-kDa centrifugal filters (Amicon) and was mixed with 0.1 mM IRDye800 
NHS ester (LI-COR) dissolved in dimethylsulfoxide (DMSO). The reaction was allowed to 
proceed for 1 h at pH 7.4 before purification to remove excess IRDye800 by filtration through 
the 30-kDa filters. The as-made SWNT-IRDye800 conjugate solution was kept at 4 °C in the 
refrigerator and away from light to avoid photobleaching of the IRDye800 fluorescence. 
13 
 
 
Sorting of large-diameter semiconducting (LS) nanotubes. A 1-cm diameter column filled 
with 20 ml of ally dextran-based size-exclusion gel (Sephacryl S-200, GE Healthcare) was used 
as filtration medium to perform diameter separation of HiPCO SWNTs.
48
 2.5 mg of raw HiPCO 
SWNTs (Unidym) was sonicated in water with 1 wt% sodium cholate (SC) for 1 h, followed by 
an ultracentrifugation at 300,000 g for 30 min to remove large bundles and aggregates. 80% of 
the SC-dispersed supernatant was collected and diluted with same volume of 1 wt% sodium 
dodecyl sulfate (SDS) solution to make a mixture of 0.5 wt% SC and 0.5 wt% SDS surfactants, 
before adding to the gel column. Metallic SWNTs passed the column directly, while 
semiconducting SWNTs were trapped. Finally, a 0.6 wt% SC/0.4 wt% SDS mixed surfactant 
solution was added to wash out and collect the LS nanotubes. 
 
UV-Vis-NIR absorption measurements. UV-Vis-NIR absorption spectra of water, 1% 
Intralipid in water and acetone, the mouse cranial bone and scalp skin were measured by a Cary 
6000i UV-Vis-NIR spectrophotometer, background-corrected for contribution from any solvent. 
The measured range was 600-1800 nm. For water and 1% Intralipid in acetone, since there was 
no scattering of light by the samples, only absorption spectra were measured. For 1% Intralipid 
in water and the mouse tissue samples, since the UV-Vis-NIR spectrometer only collected light 
at the incident angle of the beam, the scattered incident light from the sample would not be 
collected and would thus add to the absorption spectra. Therefore the obtained absorption 
spectrum for any scattering sample should really be extinction spectra, which can be considered 
as a combination of the absorption spectrum and the scattering spectrum.  
 
NIR fluorescence spectroscopy of the SWNT-IRDye800 conjugate. NIR fluorescence 
spectrum was taken using a home-built NIR spectroscopy setup in the 850-1650 nm region. The 
excitation light was provided by an 808-nm diode laser (RMPC lasers) at an output power of 160 
mW and filtered by an 850-nm short-pass filter (Thorlabs), a 1000-nm short-pass filter 
(Thorlabs), an 1100-nm short-pass filter (Omega) and a 1300-nm short-pass filter (Omega). The 
excitation light was allowed to pass through the solution sample of SWNT-IRDye800 conjugate 
in a 1 mm path cuvette (Starna Cells) and the emission was collected in the transmission 
geometry. The excitation light was rejected using an 850-nm long-pass filter (Thorlabs) so that 
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the fluorescence of both IRDye800 and SWNTs could be collected in the 850-1650 nm 
wavelength range. The emitted fluorescence from the solution sample was directed into a 
spectrometer (Acton SP2300i) equipped with a liquid-nitrogen-cooled InGaAs linear array 
detector (Princeton OMA-V). The emission spectrum was corrected after data acquisition to 
account for the laser excitation bleed-through, the sensitivity profile of the detector and 
extinction feature of the filter using the MATLAB software. 
 
Mouse handling, surgery and injection. C57Bl/6 mice were obtained from Taconic Farms. All 
animal studies were approved by Stanford University’s Administrative Panel on Laboratory 
Animal Care. Induction of middle cerebral artery occlusion (MCAO) and cerebral hypoperfusion 
was performed according to a previous study with minor modifications.
49
 Briefly, mice were 
anesthetized using 30% O2, 70% N2O, and 2% isoflurane before surgery. For induction of 
MCAO, an incision was made on the left common carotid artery (CCA) and a silicon-coated 
nylon filament (Doccol Co., CA) was introduced into the left CCA and threaded forward into 
internal carotid artery (ICA) until the tip occludes the origin of the middle cerebral artery 
(MCA). For induction of cerebral hypoperfusion, only the left external carotid artery (ECA) and 
common carotid artery (CCA) were ligated. Control, unsurgerized mice (n=3), mice with 
induced MCAO (n=4) and mice with cerebral hypoperfusion (n=4) were used in the study. The 
hair over the scalp skin was removed using Nair before tail-vein injection and imaging. All mice 
were initially anesthesized before imaging in a knockdown box with 2 L·min
-1
 O2 gas flow 
mixed with 3% Isoflurane. A nose cone delivered 1.5 L·min
-1
 O2 gas and 3% Isoflurane 
throughout imaging. For comparative cerebrovascular imaging in NIR-I, NIR-II and NIR-IIa 
regions, a solution (200 L) of 0.43 mg•mL-1 (4.3 mg•kg-1 body weight) SWNT-IRDye800 
conjugates was injected into a mouse intravenously. For dynamic imaging in the NIR-IIa region, 
a solution (200 L) of 0.43 mg•mL-1 (4.3 mg•kg-1 body weight) SWNT-DSPE-mPEG without 
IRDye800 was injected into a mouse intravenously. The maximum SWNT concentration in the 
blood circulation was ~4× lower than our previously found half maximal inhibitory 
concentration (IC50) of SWNTs to vascular endothelial cells.
22
 The blood circulation half-time 
of DSPE-mPEG functionalized SWNTs was ~5 h,
20
 and our previous studies had shown the lack 
of acute or long-term toxicity of such PEGylated SWNTs in vivo.
50-52
 For the injection of 
nanotube solution, a 28 gauge syringe needle was inserted into the tail vein, allowing for bolus 
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injection during the first frames of imaging. For steady-state imaging of the mouse head, 
injection was usually done ~5 min before the mouse was transferred to the imaging stage and 
imaged. For dynamic imaging of the mouse head, injection was done in the dark and the InGaAs 
camera started recording images continuously immediately after the nanotube solution was 
injected into the tail vein.  
 
NIR fluorescence imaging of phantom and mouse brain in different sub-regions. A liquid-
nitrogen-cooled, 320 × 256 pixel two-dimensional InGaAs array (Princeton Instruments) was 
used to take images in all sub-regions of NIR including the NIR-I, the NIR-II and the NIR-IIa 
regions. The excitation light was provided by an 808-nm diode laser (RMPC lasers) coupled to a 
collimator with a focal length of 4.5 mm (Thorlabs). The excitation light was filtered by an 850-
nm short-pass filter and a 1000-nm short-pass filter (Thorlabs) before reaching the sample on the 
imaging plane. The excitation power density at the imaging plane was 140 mW·cm
-2
, 
significantly lower than the reported safe exposure limit of 329 mW·cm
-2
 at 808 nm.
53
 The 
emitted fluorescence was allowed to pass through different filter sets to ensure the NIR images 
taken in different sub-regions. For the NIR-I region, an 850-nm long-pass filter and a 900-nm 
short-pass filter (Thorlabs) were used the confine the NIR-I region of 850-900 nm. For the NIR-
II region, a 910-nm long-pass filter and a 1000-nm long-pass filter (Thorlabs) were used to 
confine the NIR-II region of 1000-1700 nm. The upper bound at 1700 nm was determined by the 
sensitivity profile of the InGaAs detector. For the NIR-IIa region, a 1000-nm long-pass filter, a 
1300-nm long-pass filter (Thorlabs) and a 1400-nm short-pass filter (Edmund Optics) were used 
to confine the NIR-II region of 1300-1400 nm. A lens pair consisting of two achromats (200 mm 
and 75 mm, Thorlabs) was used to focus the image onto the detector with a field of view of 25 
mm × 20 mm, which covered a segment of the SWNT-IRDye800-filled capillary tube in the 
phantom imaging case and only the head and the neck area of the mouse in the in vivo brain 
imaging case. A higher magnification was also achieved by using two other NIR achromats (150 
mm and 200 mm, Thorlabs) to zoom into a smaller region of the brain. Phantom NIR 
fluorescence images were flat-field corrected to compensate for the non-uniformity of the 
excitation laser beam.  
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High resolution microscopic imaging of cerebral vessels in the NIR-IIa region. High-
magnification intravital imaging of cerebral vessels was carried out in epifluorescence mode with 
an 808-nm diode laser (RMPC lasers, 160 mW) as the excitation source and two objective lens 
(4x and 10x, Bausch & Lomb) for microscopic imaging. The mouse with scalp hair removed was 
intravenously injected with a solution (200 L) of 0.22 mg·mL-1 (2.2 mg·kg-1 body weight) 
separated LS nanotubes and placed in a home-made stereotactic platform fixed on a motorized 
3D translational stage (Newport) that allowed for the digital position adjustment and readout of 
the mouse relative to the objective. The stereotactic stage had two posts fixed on two dovetail 
linear translational stages (Thorlabs) allowing for fine adjustment to fix the motion of the mouse 
head. The resulting NIR photoluminescence was collected using the same 2D InGaAs camera as 
aforementioned. The emitted fluorescence was filtered through a 1000-nm long-pass filter, a 
1300-nm long-pass filter (Thorlabs) and a 1400-nm short-pass filter (Edmund Optics) to ensure 
only photons in the 1300–1400 nm NIR-IIa region were collected. Exposure times of 0.3–1 s 
were used for best signal-to-noise ratio. The depth of vessels was determined by first focusing 
the imaging plane onto the surface of the scalp skin, setting this as zero depth, and recording the 
axial distance the platform had travelled relative to the objective from the zero depth to reach a 
vascular image, based on the digital readout of the 3D translational stage. Since the objective 
was immersed in air, the raw axial movement of the objective was corrected to account for the 
refractive index difference of scalp skin (n=1.38),
54
 cranial bone (n=1.56)
55
 and brain tissue 
(n=1.35)
56
 and to obtain the actual imaging depth inside the brain based on Snell’s law.8  
 
Dynamic cerebral vascular imaging in the NIR-IIa window. The dynamic imaging setup was 
the same as the aforementioned NIR-IIa fluorescence brain imaging with lower magnification 
that covered the entire mouse head. The InGaAs camera was set to expose continuously, and 
fluorescence images in the NIR-IIa window were acquired with LabVIEW software. The 
exposure time for each image acquisition was 100 ms. There was also an 87.5-ms overhead time 
in the readout, leading to a total time of 187.5 ms between consecutive frames and a frame rate 
of 5.3 frames·s
-1
 for the video. Depending on the orientation of the mouse head, the time-course 
images were rotated to make the head upright in the field of view using the MATLAB built-in 
function imrotate. This turned the left and right cerebral hemispheres symmetrical in the image 
and made it easier to select ROIs for cerebral blood perfusion measurement later. Then dynamic-
17 
 
contrast-enhanced images were obtained by loading 100 consecutive frames starting from the 
frame when signal first appeared in the brain, into an array using the MATLAB software, and the 
built-in princomp function was used to perform PCA.
20,22,57
 The principal components featuring 
pixels showing up earlier in the video were automatically combined and used to represent arterial 
features while those featuring pixels showing up later in the video were combined and used to 
represent venous features based on the haemodynamic difference of arterial and venous flows.  
 
Brain blood perfusion measurement using NIR-IIa fluorescence. In a typical procedure for 
brain blood perfusion measurement, consecutive NIR-IIa images taken from dynamic imaging 
were loaded into MATLAB software, and ROIs of both the surgerized left cerebral hemisphere 
and the untreated right cerebral hemisphere were selected in the lateral sulcus region. The NIR-
IIa fluorescence intensity increase within each ROI was plotted as a function of time from 0 s to 
3.94 s (22 frames) p.i. The plot featured a linear rising edge starting at ~2 s followed by a plateau 
region due to blood saturation of NIR-IIa contrast agent. Then the plot was normalized against 
the saturation level of the control cerebral hemisphere (i.e., the right hemisphere) and the linear 
rising edge after normalization was fitted into a line with its slope proportional to blood velocity 
as proved in previous publications.
22,58
 By such analysis two slope values were obtained for each 
mouse, one derived from the control right cerebral hemisphere, and the other derived from the 
surgerized left cerebral hemisphere. Then the slope derived from the left hemisphere was 
normalized against that from right hemisphere to obtain the relative perfusion in the surgerized 
brain tissue to reveal the degree of occlusion of blood perfusion: 
                   
                                         (          ) 
                                          (       )
 
This measurement was repeated for 3-4 mice in each group to obtain statistically significant data. 
 
Vessel width analysis for NIR-IIa images. To analyze the widths of blood vessels for in vivo 
cerebral vascular imaging, all images were loaded into the ImageJ software, and a line was 
drawn perpendicular to a linear feature of interest (i.e., a blood vessel). Then the NIR-IIa 
intensity values on this line were extracted and plotted against their physical locations along this 
18 
 
line. The blood vessels intersected by the line were represented as peaks in the intensity profile 
and each peak was fitted into a Gaussian function using the Origin software.  
 
Laser Doppler flowmetry for cerebral blood perfusion measurement. Mice were 
anesthetized with 1.5% isoflurane (1.5%), O2 (30%) and N2O (70%) mixture. Body temperature 
was maintained at 36-37°C. A flexible fiberoptic probe was affixed to the skull over the MCA (2 
mm posterior and 6.5 mm lateral to bregma) after the scalp skin was removed for cerebral blood 
flow (CBF) measurements by laser Doppler flowmetry (LDF). Baseline CBF values were 
measured before vascular intervention and considered to be 100% flow. 
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Figures 
 
Figure 1 Imaging in various NIR sub-regions. (a) A fluorescence emission spectrum of SWNT-
IRDye800 conjugate in the range of 850-1650 nm under the excitation of an 808-nm laser. The 
emission spectra of IRDye800 and SWNT are plotted under different y axis scales to 
accommodate both into the same graph, due to the much higher fluorescence intensity of 
IRDye800 than SWNTs. (b) NIR fluorescence images of a capillary tube filled with SWNT-
IRDye800 solution immersed at depths of 1 mm (top) and 10 mm (bottom) in 1% Intralipid 
recorded in NIR-I, NIR-II and NIR-IIa regions respectively. (c) The extinction spectrum (black 
curve) and scattering spectrum (red curve, measured by subtracting water and Intralipid 
absorptions from the extinction spectrum, see Fig. S2) of 1% Intralipid in water with path length 
of 1 mm measured by UV-Vis-NIR spectrometer, along with reduced scattering coefficient 
profile (blue, converted to the unit of OD with base-10 common log) of 1% Intralipid derived 
from literature.
33
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Figure 2 In vivo mouse brain imaging with SWNT-IRDye800 in different NIR sub-regions. (a) 
A C57Bl/6 mouse head with hair removed. (b-d) Fluorescence images of the same mouse head 
in the NIR-I, NIR-II and NIR-IIa regions. The inferior cerebral vein, the superior sagittal sinus 
and transverse sinus are labeled 1, 2 and 3 in d, respectively. (e) Extinction spectra of scalp (red) 
and skull (blue) along with the water absorption spectrum (black). (f) Reduced scattering 
coefficients s' of scalp skin (red), cranial bone (blue) and brain tissue (black) plotted against 
wavelength, based on the previously reported scattering properties for these tissues.
8,35,36
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Figure 3 Non-invasive, high-resolution NIR-IIa fluorescence imaging of mouse brain 
vasculature. (a) A photo showing the stereotactic microscopic imaging setup, where a red laser is 
used for alignment and shows the beam location. (b) A schematic showing the penetration of 
NIR-IIa fluorescence through brain tissue, skull and the scalp. (c) A photoluminescence versus 
excitation (PLE) spectrum of LS nanotubes in an aqueous solution. The 1.3-1.4 m NIR-IIa 
region is shaded red. (d) A low-magnification cerebral vascular image taken with a field of view 
of 25 mm × 20 mm. (e) A cerebral vascular image of the same mouse head zoomed into the left 
cerebral hemisphere, with a field of view of 8 mm × 6.4 mm. (f) A cerebral vascular image of the 
same mouse head taken using a microscope objective, with a field of view of 1.7 mm × 1.4 mm. 
The depth of these in-focus vascular features was determined as 2.6 mm. (g) A zoomed-in image 
of a sub-region in f taken by a higher magnification objective, with a field of view of 0.80 mm × 
0.64 mm. The inset shows the cross-sectional intensity profile (black) and Gaussian fit (red) 
along the yellow-dashed bar. (h-k) Two other high resolution cerebral vascular images with a 
field of view of 0.80 mm × 0.64 mm taken on another mouse (h&j), and their cross-sectional 
fluorescence intensity profiles (black) and Gaussian fit (red) along the yellow-dashed bars (i&k). 
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Figure 4 Dynamic NIR-IIa fluorescence imaging of mouse cerebral vasculature. (a-c) Time 
course NIR-IIa images of a control, healthy mouse (Mouse C1). (d-f) PCA overlaid images 
showing arterial (red) and venous (blue) vessels of Mouse C1. (g-i) Time course NIR-IIa images 
of a mouse with MCAO (Mouse M1). (j-l) PCA overlaid images showing arterial (red) and 
venous (blue) vessels of Mouse M1. (m-n) Normalized NIR-IIa signal in the left (red) and right 
(black) cerebral hemispheres of Mouse C1 (m) and M1 (n) versus time. (o) Average blood 
perfusion of the left cerebral hemisphere of control group (n=3), MCAO group (n=4) and 
cerebral hypoperfusion group (n=4), measured by NIR-II method (red) and laser Doppler blood 
spectroscopy (blue). Errors bars reflect the standard deviation of each group.  
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Figure S1 NIR fluorescence images of a capillary tube filled with SWNT-IRDye800 solution 
immersed at depths of 1 mm (a, e, i), 4 mm (b, f, j), 7 mm (c, g, k) and 10 mm (d, h, l) in 1% 
Intralipid recorded in NIR-I (a-d), NIR-II (e-h) and NIR-IIa (i-l) regions respectively. 
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Figure S2 Determination of the scattering spectrum of 1% Intralipid in water.  The scattering 
spectrum (red curve) was obtained by subtracting the absorption of water (green curve) and 
absorption of 1% Intralipid in an organic solvent (blue curve; acetone forms a non-scattering 
solution for Intralipid) from the as-measured extinction spectrum of 1% Intralipid aqueous 
solution (black curve). 
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Figure S3 A schematic of the NIR-IIa fluorescence imaging rig for non-invasive through-scalp 
and through-skull brain vascular imaging.  
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Figure S4 Physical measurement of the total thickness of scalp skin, cranial bone and the 
meninges of a C57Bl/6 mouse. (a) A digital camera photo of a dissected mouse head. The scalp, 
skull and meninges over the right cerebral hemisphere were completed removed while those over 
the left hemisphere remained intact. Note that the mouse was perfused with 5% Evans blue 
before sacrifice to render the vessels blue in the brain. (b-d) A repeated measure of the total 
thickness of scalp skin, cranial bone and the meninges by digital calipers at three different 
locations. The average thickness was 1.37 mm, setting the lower bound of cerebral vessel depths 
in our imaging experiments. Therefore the cortical vessels located at the surface of the brain, 
including the inferior cerebral vein, the superior sagittal sinus and the transverse sinus, should 
have depths within the range of 1-2 mm underneath the scalp skin. 
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Figure S5 Photoluminescence versus excitation (PLE) spectra of unseparated HiPCO SWNTs 
(top) and separated LS nanotubes (bottom) in aqueous solutions. The 1.3-1.4 m NIR-IIa region 
is shaded red in both spectra to highlight the difference of fluorescence emission of the two 
samples in this region (enhanced emission in the region for separated LS nanotubes).  Note that 
metallic nanotubes with no fluorescence were mostly removed in the separated LS sample. 
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Figure S6 More microscopic images of brain vessels recorded in the NIR-IIa region at depths in 
the range of 1-3 mm underneath the surface of the scalp skin of several mice. Images a&b were 
taken under a 4x microscopic objective with a field of view of 1.7 mm × 1.4 mm, while images 
c-f were taken under a 10x microscopic objective with a field of view of 800 m × 640 m. 
Cross-sectional fluorescence intensity profiles (black) along the green-dashed bars in the images 
are shown under each corresponding image, and Gaussian fitted peaks to the profiles are shown 
as the red curves, featuring capillary vessel widths in the range of 6-16 m.  
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Figure S7 Statistical analysis of capillary vessel widths in NIR-IIa fluorescence images. (a-f) 
Microscopic cerebral vascular images with the analyzed capillary vessels intersected with green 
dashed bars. (g) A histogram showing the distribution of measured capillary vessel widths in the 
range of 5-15 m, with a mean vessel width of 9.4 m and a standard deviation of 2.5 m.  
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Figure S8 NIR-IIa fluorescence images taken at different time points post injection (p.i.), 
between which we returned the mouse to its cage for it to recover from anesthesia. These time-
course images show a time window of ~3 h p.i. for static brain vessel imaging. Note that in the 
last two images a tape was applied on part of the scalp skin to cover a wound possibly caused by 
the bite from another mouse in the same cage.  
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Figure S9 Dynamic NIR-IIa fluorescence imaging of mouse cerebral vasculature on a group of 
control mice (Mouse C2 & C3) at a frame rate of 5.3 frames•s-1. (a-c) Time course NIR-IIa 
fluorescence images showing blood flow in the cerebral vasculature of Mouse C2. (d) PCA 
overlaid image based on the first 100 frames (18.75 s post injection) of Mouse C2. (e-g) Time 
course NIR-IIa fluorescence images showing blood flow in the cerebral vasculature of Mouse 
C3. (h) PCA overlaid image based on the first 100 frames (18.75 s post injection) of Mouse C3. 
(i) Normalized NIR-IIa signal in the left (red) and right (black) cerebral hemispheres of Mouse 
C2 versus time. (j) Normalized NIR-IIa signal in the left (red) and right (black) cerebral 
hemispheres of Mouse C3 versus time.  
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Figure S10 Dynamic NIR-IIa fluorescence imaging of mouse cerebral vasculature on a group of 
MCAO mice (Mouse M2-4) at a frame rate of 5.3 frames•s-1. (a-c) Time course NIR-IIa 
fluorescence images showing blood flow in the cerebral vasculature of Mouse M2. (d) PCA 
overlaid image based on the first 100 frames (18.75 s post injection) of Mouse M2. (e-g) Time 
course NIR-IIa fluorescence images showing blood flow in the cerebral vasculature of Mouse 
M3. (h) PCA overlaid image based on the first 100 frames (18.75 s post injection) of Mouse M3. 
(i-k) Time course NIR-IIa fluorescence images showing blood flow in the cerebral vasculature of 
Mouse M4. (l) PCA overlaid image based on the first 100 frames (18.75 s post injection) of 
Mouse M4. (m) Normalized NIR-IIa signal in the left (red) and right (black) cerebral 
hemispheres of Mouse M2 versus time. (n) Normalized NIR-IIa signal in the left (red) and right 
(black) cerebral hemispheres of Mouse M3 versus time. (o) Normalized NIR-IIa signal in the left 
(red) and right (black) cerebral hemispheres of Mouse M4 versus time. 
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Figure S11 Dynamic NIR-IIa fluorescence imaging of mouse cerebral vasculature on a group of 
mice with cerebral hypoperfusion (Mouse H1-4) at a frame rate of 5.3 frames•s-1. (a-c) Time 
course NIR-IIa fluorescence images showing blood flow in the cerebral vasculature of Mouse 
H1. (d) PCA overlaid image based on the first 100 frames (18.75 s post injection) of Mouse H1. 
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(e-g) Time course NIR-IIa fluorescence images showing blood flow in the cerebral vasculature 
of Mouse H2. (h) PCA overlaid image based on the first 100 frames (18.75 s post injection) of 
Mouse H2. (i-k) Time course NIR-IIa fluorescence images showing blood flow in the cerebral 
vasculature of Mouse H3. (l) PCA overlaid image based on the first 100 frames (18.75 s post 
injection) of Mouse H3. (m-o) Time course NIR-IIa fluorescence images showing blood flow in 
the cerebral vasculature of Mouse H4. (p) PCA overlaid image based on the first 100 frames 
(18.75 s post injection) of Mouse H4. (q) Normalized NIR-IIa signal in the left (red) and right 
(black) cerebral hemispheres of Mouse H1 versus time. (r) Normalized NIR-IIa signal in the left 
(red) and right (black) cerebral hemispheres of Mouse H2 versus time. (s) Normalized NIR-IIa 
signal in the left (red) and right (black) cerebral hemispheres of Mouse H3 versus time. (t) 
Normalized NIR-IIa signal in the left (red) and right (black) cerebral hemispheres of Mouse H4 
versus time. 
 
